Market Movers (8-K)
See all →OTC.Pink
Crown Electrokinetics Corp. has amicably terminated its engagement with Frank, Rimerman + Co. LLP and appointed CBIZ CPAs P.C. as its new independent registered public accounting firm, effective January 12, 2026.
OTC.Pink
Crown Electrokinetics' subsidiary, Crown Fiber Optics Corp., sold its fiber optics and construction assets to Paramount Infrastructure Corp. for $2 million.
OTC.Pink
Crown Electrokinetics Corp. announced the resignation of Joel Krutz from its Board of Directors and his subsequent termination as Chief Operating Officer and Chief Financial Officer.
Worse than expected
OTC.Pink
Crown Electrokinetics Corp. has engaged Frank, Rimerman + Co. LLP as its independent registered public accounting firm for the 2025 fiscal year.
OTC.Pink
Crown Electrokinetics Corp. announced the appointment of Chris Robichaud to its Board of Directors, who will also chair the Audit Committee.
OTC.Pink
Crown Electrokinetics Corp.'s independent auditor, BPM LLP, has resigned effective August 1, 2025, though not due to fraud or legal violations, while the company seeks a replacement.
Delay expected
Worse than expected
Quarterly Earnings (10-Q)
OTC.Pink
Crown Electrokinetics Corp. reports increased revenue for Q1 2025 but expresses substantial doubt about its ability to continue as a going concern.
Worse than expected
OTC.Pink
Crown Electrokinetics Corp. saw a significant increase in revenue during the third quarter of 2024, driven by its Fiber Optics and Water Solutions divisions, but continues to experience net losses.
Worse than expected
Capital raise
OTC.Pink
Crown Electrokinetics Corp. saw a significant increase in revenue during the second quarter of 2024, primarily driven by its fiber optics segment, but continues to experience substantial net losses.
Worse than expected
Capital raise
OTC.Pink
Crown Electrokinetics Corp. saw a significant increase in revenue from its fiber optics segment in the first quarter of 2024, while also reporting a net loss and ongoing concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
Annual Reports (10-K)
OTC.Pink
Crown Electrokinetics Corp. reports a significant revenue increase driven by its Fiber Optics and Water Solutions divisions, but faces challenges including a Nasdaq delisting and ongoing financial losses.
Capital raise
Worse than expected
OTC.Pink
10-K: Crown Electrokinetics Corp. Details Securities and Financial Performance in Annual 10-K Filing
Crown Electrokinetics Corp.'s annual 10-K filing details the company's registered securities, financial performance, and strategic initiatives in electrokinetic film and fiber optics.
Delay expected
Capital raise
Worse than expected
Insider Trading (Form 4)
See all →OTC.Pink
Director Scott Hobbs acquired 32,704 shares of Crown Electrokinetics Corp. restricted stock under the company's employee incentive plans.
OTC.Pink
Director Dipanjan Nag acquired restricted stock in Crown Electrokinetics Corp. under the company's employee incentive plans.
OTC.Pink
Director Daniel Marcus acquired 32,704 shares of Crown Electrokinetics Corp. restricted stock through grants under the company's 2022 and 2024 Employee Incentive Plans.
OTC.Pink
Joel Krutz, CFO and COO of Crown Electrokinetics Corp., reports the acquisition of restricted stock grants under the company's 2022 and 2024 Employee Incentive Plans.
OTC.Pink
Douglas Croxall, CEO of Crown Electrokinetics Corp., reports the acquisition of restricted stock grants under the company's 2022 and 2024 Employee Incentive Plans.
OTC.Pink
CFO and Chief Operating Officer of Crown Electrokinetics Corp., Joel Krutz, was granted 538,837 restricted stock units on October 27, 2023, vesting monthly over 12 months or immediately upon the company reaching a $50 million market capitalization.
Proxy Statements (Def-14A)
OTC.Pink
Crown Electrokinetics Corp. is holding a special meeting to seek stockholder approval for a reverse stock split and to ratify the appointment of their new independent auditor.
Worse than expected
OTC.Pink
Crown Electrokinetics amended its bylaws to reduce the quorum requirement for stockholder meetings to one-third, effective retroactively for the upcoming Annual Meeting on June 14, 2024.
OTC.Pink
Crown Electrokinetics is asking stockholders to approve several key proposals at its upcoming annual meeting, including a reverse stock split, a new employee incentive plan, and the potential issuance of shares to an accredited investor.
Worse than expected
Capital raise
New Public Companies (S-1)
OTC.Pink
Crown Electrokinetics Corp. files for a resale registration statement, paving the way for potential sales of up to $100 million in common stock to Liqueous LP under a recently established purchase agreement.
Capital raise
OTC.Pink
Crown Electrokinetics plans to raise up to $36.3 million through the resale of 300 million shares by Keystone Capital Partners, as detailed in a recent S-1 filing.
Worse than expected
Capital raise
OTC.Pink
Crown Electrokinetics has filed a registration statement for the resale of up to 200 million shares of its common stock by Keystone Capital Partners.
Worse than expected
Capital raise